Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA HOTAIR Interaction With WTAP Promotes m6A Methyltransferase Complex Assembly and Posterior Capsule Opacification Formation by Increasing THBS1. | Invest Ophthalmol Vis Sci | 2025 | 40341312 | PubTator, text mining | PubMed |
| A Novel Diagnostic and Subtype Classification Model Based on RNA N6-Methyladenosine Regulators for Behçet's Uveitis. | Ocul Immunol Inflamm | 2025 | 40338700 | PubTator, text mining | PubMed |
| m6A/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability. | Nat Commun | 2025 | 40328743 | PubTator, text mining | PubMed |
| [m6A modification regulates PLK1 expression and mitosis]. | Sheng Wu Gong Cheng Xue Bao | 2025 | 40328716 | PubTator, text mining | PubMed |
| The m6A methylation system limits hepatitis B virus replication. | Biomed Khim | 2025 | 40326019 | PubTator, text mining | PubMed |
| FTO downregulation-mediated m6A modification resulting in enhanced hepatocellular carcinoma invasion. | Cell Biosci | 2025 | 40316995 | PubTator, text mining | PubMed |
| SETD5 facilitates stemness and represses ferroptosis via m6A-mediating PKM2 stabilization in non-small cell lung cancer. | Oncogene | 2025 | 40307507 | PubTator, text mining | PubMed |
| METTL14 regulates chondrogenesis through the GDF5-RUNX-extracellular matrix gene axis during limb development. | Nat Commun | 2025 | 40307229 | PubTator, text mining | PubMed |
| Thiamine and METTL14 in Diabetes Management with Intensive Insulin Therapy. | Biomedicines | 2025 | 40299682 | PubTator, text mining | PubMed |
| PRPS2 enhances RNA m6A methylation by stimulating SAM synthesis through enzyme-dependent and independent mechanisms. | Nat Commun | 2025 | 40295500 | PubTator, text mining | PubMed |
| SLC27A5 inhibits cancer stem cells by inducing alternative polyadenylation of METTL14 in hepatocellular carcinoma. | Genes Dis | 2025 | 40290127 | PubTator, text mining | PubMed |
| The METTL14-YTHDF1-SAP30 Axis Promotes Glycolysis and Oxaliplatin Resistance in Colorectal Adenocarcinoma via m6A Modification. | J Gastroenterol Hepatol | 2025 | 40289460 | PubTator, text mining | PubMed |
| Aberrant overexpression of m6A writer and reader genes in pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL). | Transl Oncol | 2025 | 40288000 | PubTator, text mining | PubMed |
| Corrigendum to "PRMT1 methylates METTL14 to modulate its oncogenic function" [Neoplasia 42 (2023) 100912]. | Neoplasia | 2025 | 40273836 | PubTator, text mining | PubMed |
| METTL14 promotes intimal hyperplasia through m6A-mediated control of vascular smooth muscle dedifferentiation genes. | JCI Insight | 2025 | 40266881 | PubTator, text mining | PubMed |
| Lnc-HZ06 down-regulates HIF1α protein levels in CoCl2-exposed hypoxic trophoblast cells and villous tissues of miscarriage patients. | Sci Total Environ | 2025 | 40262219 | PubTator, text mining | PubMed |
| PAK5 promotes the trastuzumab resistance by increasing HER2 nuclear accumulation in HER2-positive breast cancer. | Cell Death Dis | 2025 | 40258843 | PubTator, text mining | PubMed |
| METTL14-mediated m6A RNA methylation promotes the osteogenic differentiation of pPDLSCs by regulating WNT3A. | Odontology | 2025 | 40249476 | PubTator, text mining | PubMed |
| Epigenetics of maternal-fetal interface immune microenvironment and placental related pregnancy complications. | Front Immunol | 2025 | 40248704 | PubTator, text mining | PubMed |
| Identification of ferroptosis-related gene signatures in temporal lobe epilepsy with hippocampal sclerosis. | Front Neurosci | 2025 | 40242460 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=18